Streetbeat News

Revenues

THC

Tenet Healthcare Corporation (NYSE:THC) reported strong Q3 results, with sales of $5.12 billion and adjusted EPS of $2.93, both exceeding expectations. The company raised its annual forecast due to robust same-store revenue and free cash flow growth. THC stock rose 12.01% following the announcement.

Portfolio Pulse from Vandana Singh

October 29, 2024 | 3:02 pm

HRMY

Harmony Biosciences (NASDAQ:HRMY) has received predominantly bullish ratings from analysts, with a 12-month average price target of $51.11, reflecting a slight increase. The company shows strong revenue growth and net margin but has a lower ROE compared to industry benchmarks.

Portfolio Pulse from Benzinga Insights

October 29, 2024 | 3:02 pm

AMKR

Analysts have varied ratings for Amkor Tech (NASDAQ:AMKR), with recent price targets averaging $33, down from $39.33. Analysts from Keybanc, Morgan Stanley, and Needham have lowered their price targets, reflecting a cautious outlook. Amkor Tech faces challenges with below-industry-average net margin, ROE, and ROA, despite a positive revenue trend.

Portfolio Pulse from Benzinga Insights

October 29, 2024 | 3:01 pm

LNG

The article evaluates Cheniere Energy (NYSE:LNG) against its peers in the Oil, Gas & Consumable Fuels industry, highlighting its financial metrics. Cheniere Energy shows a low P/E ratio, suggesting undervaluation, but a high P/B ratio indicates potential overvaluation. The company has a high ROE but faces challenges with low EBITDA, gross profit, and negative revenue growth.

Portfolio Pulse from Benzinga Insights

October 29, 2024 | 3:01 pm

WMT

The article provides a comprehensive analysis of Walmart (NYSE:WMT) compared to its competitors in the Consumer Staples Distribution & Retail industry. It highlights Walmart's premium valuation with high P/E, P/B, and P/S ratios, but notes challenges in profitability and growth metrics. Despite these challenges, Walmart's lower debt-to-equity ratio suggests a stronger financial position compared to its peers.

Portfolio Pulse from Benzinga Insights

October 29, 2024 | 3:00 pm

PLTR

The article provides an analysis of Palantir Technologies (NYSE:PLTR) in comparison to its competitors in the software industry. It highlights Palantir's high valuation metrics, such as P/E, P/B, and P/S ratios, indicating potential overvaluation. Despite lower profitability metrics like ROE, EBITDA, and gross profit, Palantir shows strong revenue growth and a favorable debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

October 29, 2024 | 3:00 pm

CSTL

Castle Biosciences (NASDAQ:CSTL) has received mixed analyst ratings over the past three months, with a recent increase in average price target to $39.0. Analysts have shown a bullish sentiment, with some raising their price targets. The company has demonstrated strong financial performance with significant revenue growth and profitability metrics.

Portfolio Pulse from Benzinga Insights

October 29, 2024 | 3:00 pm

ORCL

Oracle (NYSE:ORCL) has significantly outperformed the market over the past 5 years, with an annualized return of 25.48%. A $100 investment in Oracle 5 years ago would now be worth $313.68, highlighting the power of compounded returns.

Portfolio Pulse from Benzinga Insights

October 29, 2024 | 3:00 pm

GBDC

Analysts have provided mixed ratings for Golub Capital BDC (NASDAQ:GBDC) over the past three months, with a slight decrease in the average price target. The company's financials show a significant decline in revenue but strong net margins. Analysts' ratings and price targets offer insights into the company's market position.

Portfolio Pulse from Benzinga Insights

October 29, 2024 | 3:00 pm

SMCI

Super Micro Computer (NASDAQ:SMCI) has significantly outperformed the market over the past 15 years, with an average annual return of 31.71%. A $100 investment in SMCI 15 years ago would now be worth $6,093.75. This highlights the power of compounded returns.

Portfolio Pulse from Benzinga Insights

October 29, 2024 | 3:00 pm